Phase I Trial of a Lactobacillus crispatus Vaginal Suppository for Prevention of Recurrent Urinary Tract Infection in Women
2007

Lactobacillus Suppository for Preventing Urinary Tract Infections

Sample size: 30 publication 10 minutes Evidence: moderate

Author Information

Author(s): Czaja Christopher A., Stapleton Ann E., Yarova-Yarovaya Yuliya, Stamm Walter E.

Primary Institution: University of Washington School of Medicine

Hypothesis

Can a Lactobacillus vaginal suppository prevent recurrent urinary tract infections in women?

Conclusion

L. crispatus CTV-05 can be given as a vaginal suppository with minimal side effects to healthy women with a history of recurrent UTI.

Supporting Evidence

  • 30 women were randomized with no severe adverse events reported.
  • Mild to moderate vaginal discharge and irritation were common but not severe.
  • Seven women developed pyuria without associated symptoms.
  • Most women had high concentrations of vaginal H2O2-producing lactobacilli before randomization.

Takeaway

This study tested a probiotic suppository to help prevent urinary infections in women, and it was mostly safe with few side effects.

Methodology

Premenopausal women with recurrent UTIs were randomized to use L. crispatus CTV-05 or placebo vaginal suppositories daily for five days.

Potential Biases

Potential bias due to self-reported symptoms and small sample size.

Limitations

The study was small and not designed to evaluate the effect on UTI recurrence.

Participant Demographics

Young, healthy, mostly white university students aged 18-35 with a history of recurrent UTIs.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1155/2007/35387

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication